Management of Cabozantinib-Associated Adverse Events in the Treatment of Advanced Renal Cell Carcinoma, Hepatocellular Carcinoma, and Radioiodine-Refractory Differentiated Thyroid Cancer.

Autor:	Lee-Ramos, Steven, Seery, Virginia, Andresen, Diane, Hall, Tasha, Berry, Nicholas, Martone, Brenda
Předmět:	THERAPEUTIC use of antineoplastic agents THYROID gland tumors IODINE radioisotopes DRUG side effects PROTEIN-tyrosine kinase inhibitors CONFERENCES & conventions RENAL cell carcinoma HEPATOCELLULAR carcinoma
Zdroj:	Journal of Oncology Navigation & Survivorship; Oct2024, Vol. 15 Issue 10, p311-312, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu